Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup
- PMID: 19064538
- PMCID: PMC3037017
- DOI: 10.3945/ajcn.2008.25825D
Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup
Abstract
Our laboratory has investigated 2 hypotheses regarding the effects of fructose consumption: 1) the endocrine effects of fructose consumption favor a positive energy balance, and 2) fructose consumption promotes the development of an atherogenic lipid profile. In previous short- and long-term studies, we showed that consumption of fructose-sweetened beverages with 3 meals results in lower 24-h plasma concentrations of glucose, insulin, and leptin in humans than does consumption of glucose-sweetened beverages. We have also tested whether prolonged consumption of high-fructose diets leads to increased caloric intake or decreased energy expenditure, thereby contributing to weight gain and obesity. Results from a study conducted in rhesus monkeys produced equivocal results. Carefully controlled and adequately powered long-term studies are needed to address these hypotheses. In both short- and long-term studies, we showed that consumption of fructose-sweetened beverages substantially increases postprandial triacylglycerol concentrations compared with glucose-sweetened beverages. In the long-term studies, apolipoprotein B concentrations were also increased in subjects consuming fructose, but not in those consuming glucose. Data from a short-term study comparing consumption of beverages sweetened with fructose, glucose, high-fructose corn syrup, and sucrose suggest that high-fructose corn syrup and sucrose increase postprandial triacylglycerol to an extent comparable with that induced by 100% fructose alone. Increased consumption of fructose-sweetened beverages along with increased prevalence of obesity, metabolic syndrome, and type 2 diabetes underscore the importance of investigating the metabolic consequences of fructose consumption in carefully controlled experiments.
Conflict of interest statement
The authors have no conflicts of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3037017/bin/nihms269839f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3037017/bin/nihms269839f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3037017/bin/nihms269839f3.gif)
Similar articles
-
Effects of Consuming Sugar-Sweetened Beverages for 2 Weeks on 24-h Circulating Leptin Profiles, Ad Libitum Food Intake and Body Weight in Young Adults.Nutrients. 2020 Dec 19;12(12):3893. doi: 10.3390/nu12123893. Nutrients. 2020. PMID: 33352724 Free PMC article. Clinical Trial.
-
Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people.Adv Nutr. 2013 Mar 1;4(2):220-5. doi: 10.3945/an.112.002816. Adv Nutr. 2013. PMID: 23493538 Free PMC article. Review.
-
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.J Clin Invest. 2009 May;119(5):1322-34. doi: 10.1172/JCI37385. Epub 2009 Apr 20. J Clin Invest. 2009. PMID: 19381015 Free PMC article.
-
Straight talk about high-fructose corn syrup: what it is and what it ain't.Am J Clin Nutr. 2008 Dec;88(6):1716S-1721S. doi: 10.3945/ajcn.2008.25825B. Am J Clin Nutr. 2008. PMID: 19064536 Review.
-
Twenty-four-hour endocrine and metabolic profiles following consumption of high-fructose corn syrup-, sucrose-, fructose-, and glucose-sweetened beverages with meals.Am J Clin Nutr. 2008 May;87(5):1194-203. doi: 10.1093/ajcn/87.5.1194. Am J Clin Nutr. 2008. PMID: 18469239 Free PMC article. Clinical Trial.
Cited by
-
Effects of Excessive High-fructose Corn Syrup Drink Intake in Middle-aged Mice.In Vivo. 2024 May-Jun;38(3):1152-1161. doi: 10.21873/invivo.13550. In Vivo. 2024. PMID: 38688615 Free PMC article.
-
Acute Intake of Fructose Increases Arterial Pressure in Humans: A Meta-Analysis and Systematic Review.Nutrients. 2024 Jan 10;16(2):219. doi: 10.3390/nu16020219. Nutrients. 2024. PMID: 38257112 Free PMC article. Review.
-
Effects of Natural Alternative Sweeteners on Metabolic Diseases.Clin Nutr Res. 2023 Jul 26;12(3):229-243. doi: 10.7762/cnr.2023.12.3.229. eCollection 2023 Jul. Clin Nutr Res. 2023. PMID: 37593210 Free PMC article. Review.
-
Longitudinal analysis for the risk of depression according to the consumption of sugar-sweetened carbonated beverage in non-diabetic and diabetic population.Sci Rep. 2023 Aug 9;13(1):12901. doi: 10.1038/s41598-023-40194-6. Sci Rep. 2023. PMID: 37558774 Free PMC article.
-
The effect of high-fructose corn syrup vs. sucrose on anthropometric and metabolic parameters: A systematic review and meta-analysis.Front Nutr. 2022 Sep 27;9:1013310. doi: 10.3389/fnut.2022.1013310. eCollection 2022. Front Nutr. 2022. PMID: 36238453 Free PMC article.
References
-
- Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004;79:537–543. - PubMed
-
- Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr. 2002;76:911–922. - PubMed
-
- Havel PJ. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev. 2005;63:133–157. - PubMed
-
- Le KA, Tappy L. Metabolic effects of fructose. Curr Opin Clin Nutr Metab Care. 2006;9:469–475. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- DK-58108/DK/NIDDK NIH HHS/United States
- AT-002993/AT/NCCIH NIH HHS/United States
- R21 AT002599/AT/NCCIH NIH HHS/United States
- R01 HL075675-02/HL/NHLBI NIH HHS/United States
- R01 HL075675-04/HL/NHLBI NIH HHS/United States
- RR-00169/RR/NCRR NIH HHS/United States
- AT-003545/AT/NCCIH NIH HHS/United States
- R21 AT002993/AT/NCCIH NIH HHS/United States
- UL1 RR024146/RR/NCRR NIH HHS/United States
- R01 HL075675/HL/NHLBI NIH HHS/United States
- AT-002599/AT/NCCIH NIH HHS/United States
- R03 DK058108-02/DK/NIDDK NIH HHS/United States
- HL-091333/HL/NHLBI NIH HHS/United States
- R03 DK058108/DK/NIDDK NIH HHS/United States
- R01 HL075675-05/HL/NHLBI NIH HHS/United States
- R03 DK058108-01A1/DK/NIDDK NIH HHS/United States
- P51 RR000169/RR/NCRR NIH HHS/United States
- HL-075675/HL/NHLBI NIH HHS/United States
- R01 HL107256/HL/NHLBI NIH HHS/United States
- R01 HL091333-01/HL/NHLBI NIH HHS/United States
- R01 HL075675-03/HL/NHLBI NIH HHS/United States
- R01 HL091333/HL/NHLBI NIH HHS/United States
- R01 HL075675-01A1/HL/NHLBI NIH HHS/United States
- UL1 RR024146-03/RR/NCRR NIH HHS/United States